Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Old Dominion Dispatch.
Press releases published on October 17, 2025
Chart Lens IQ and U.S. Urology Partners Launch AI Clinical Insight Platform at Central Ohio Urology Group
Chart Lens IQ™ partners with U.S. Urology Partners in next-generation AI analytics, patient identification, and navigation systems to outpatient urology care. TYSONS CORNER, VA, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- Chart Lens IQ, Inc., …
Innovative Recording Artist Louissa Unveils Her EP 'THE VAULT' A Cathartic Reflection of Growth and Self-Discovery
Innovative Recording Artist Louissa Unveils Her EP “THE VAULT” — A Cathartic Reflection of Growth and Self-Discovery VIRGINIA BEACH, VIRGINIA, VA, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Innovative and multi-talented recording artist …
Historic Building in the Downtown Central Business Dist of Richmond, VA Set for Auction Announces Nicholls Auction Mktg
"The Virginia Trust Company Building" (circa 1919): A Standout Historic Gem in the Heart of Richmond's Central Business District Set for Auction FREDERICKSBURG, VA, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- Nicholls Auction Marketing Group, …
Freddie Mac Announces Results of Tender Offer for Certain STACR Notes
MCLEAN, Va., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) (the “Company”) today announced the tender results of its previously announced offer to purchase (the “Offer”) any and all of the STACR® (Structured Agency Credit Risk) Notes listed …
Cellebrite to Report Third-Quarter 2025 Financial Results on November 12, 2025
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2025 …
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show
GLEN ALLEN, Va., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …